Mark T. Fleming, MD, Medical Oncology, Medical Director, Genitourinary Program, US Oncology, Virginia Oncology Associates, Discusses The LATITUDE Study In NDx-HR mCNPC. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019.
http://obroncology.com